Skip to main content
. 2020 Oct;74(5):346–349. doi: 10.5455/medarh.2020.74.346-349

Table 1. Serum concentration of CEA and CA 19-9 in colorectal cancer patients in relation to cancer stage. Data are presented as median and interquartile range q1-q3. *p<0.05 between stage II and IV; ǂp<0.05 between stage III and IV.

Stage of CRC
Variabe I
(n=2)
II
(n=27)
III
(n=46)
IV
(n=5)
CEA (mcg/L) 0.77
(0.37-0.78)
3.60
(2.42-13.90)
4.34
(1.77-20.44)
29.3
(2.05-606.5)
CA 19-9
(U/mL)
5.03
(2.74-4.80)
10.33
(6.54-26.34)
8.21
(3.67-20.14)
343,00*ǂ
(35.9-1675.4)